The Supply Chain Matters blog highlights how current and future COVID-19 vaccine supply has drawn active supply chain resiliency actions. In an example is Moderna’s announced deal with Canada to build and operate a domestic MRNA vaccine production facility in that country.
The Johnson & Johnson Vaccine Production Mix-up- The Message of Stepped-Up Quality Monitoring and Controls
The Supply Chain Matters blog provides commentary on last week’s revelation of a COVID-19 vaccine production facility’s snafu in producing the Johnson & Johnson vaccine. The commentary addresses what mitigation actions the industry needs to undertake to insure the quality needs of COVID-19 vaccines produced at such volumes.